Mim8 prophylaxis in children with haemophilia A: 52-week efficacy and safety outcomes from FRONTIER3

Feb 6, 2026 — 02:45 pm - 3:00 PM
The Auditorium

Main session
Presenter:
Johnny Mahlangu